Skip to content

Evaluation efficacy of black tea tablets Effect in treatment of acute non-bacterial diarrhea

Randomized clinical trial : Evaluation of black tea tablets Effect in treatment of acute non-bacterial diarrhea in 2-12 years old patients referred to dastgheib hospital in Shiraz

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108272434N6
Enrollment
120
Registered
2012-03-31
Start date
2011-08-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Non-Bacterial Diarrhea. Viral and other specified intestinal infections , Other gastroenteritis and colitis of infectious and unspecified origin

Interventions

Intervention 1: Intervention: Single dose of black tea tablet and standard treatment
This drug is made from ordinary black tea in tablet form.In 2-6 years old children Was prescribed one tablet as a single dose and 6-12 years old children two tablet as a single dose. Intervention 2: C
Treatment - Drugs
Intervention: Single dose of black tea tablet and standard treatment
This drug is made from ordinary black tea in tablet form.In 2-6 years old children Was prescribed one tablet as a single dose and 6-12 years old children two tablet as a single dose.
Control: Standard treatment (ORS)

Sponsors

Vice Chancellor for Research, Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion: There diarrhea (defined as the science) at least 3 times in 24 hours; Exclusion:bloody and mocoid diarrhea(+OB) ; Lack of access to patients in the next 24 hours ; Confirmed the diagnosis of acute non-bacterial diarrhea and need special treatment ; Gastrointestinal diseases such as celiac disease and lactose deficiency and ... ; Underlying problems such as diabetes, reduced immune system and ...

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in Bowel Frequency. Timepoint: Before intervention and 24 hours later. Method of measurement: Questionaire.;Change in Stool Consistency. Timepoint: Before intervention and 24 hours later. Method of measurement: Questionaire.;Change in stool Volume. Timepoint: Before intervention and 24 hours later. Method of measurement: Questionaire.

Secondary

MeasureTime frame
Require the use of ORS or IV injection. Timepoint: Every 6 hours. Method of measurement: Questions from Parents-Nurses.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSare Doust Fateme

Shiraz University of Medical Sciences

sare_doustfateme@yahoo.com ; zahra.torkamani@gmail.com+98 71 1634 4527

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026